Evidence map›Paper›PMID 40302841›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

Diagnosis and management of patients with fulminant myocarditis.

Nicoletta D'Ettore, Kaveh Eghbalzadeh, Mehmet Oezkur, Letizia F Bertoldi, Matthias Bossard, Federico Pappalardo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicoletta D'EttoreDepartment of Cardiology, San Giacomo Hospital, Novi Ligure - AS LAL, Via Edilio Raggio 12, Alessandria 15067, Italy.ORCID https://orcid.org/0000-0002-0240-7395
Kaveh EghbalzadehDepartment of Cardiac Surgery, Heart Center Bonn, University Hospital Bonn, 53127 Bonn, Germany.
Mehmet OezkurDepartment of Cardiovascular Surgery, University Hospital of Mainz, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.ORCID https://orcid.org/0000-0002-1284-066X
Letizia F BertoldiCardio Center, Humanitas Clinical and Research Center-IRCCS, Rozzano, MI, 20089 Italy.
Matthias BossardHeart Center, Luzerner Kantonsspital, 6000 Luzern, Switzerland.
Federico PappalardoKore University, Enna and Policlinico Centro Cuore GB Morgagni, 94100 Catania, Italy.ORCID https://orcid.org/0000-0001-9129-833X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fulminant myocarditis (FM) is a progressive and severe form of acute myocarditis, complicated by cardiogenic shock. The clinical presentation and aetiologies of FM are often heterogeneous, making it difficult to diagnose. Irrespective of how FM presents, it rapidly evolves to haemodynamic deterioration and requires prompt treatment to stabilize. As such, the use of mechanical circulatory support (MCS) devices has emerged as a critical intervention to achieve haemodynamic support, early unloading, and systemic perfusion and to prevent multiorgan dysfunction in patients with FM. Although scientific societies have proposed recommendations and management pathways, due to the heterogeneity in FM, there remains a lack of clarity in the diagnostic pathway and selection of MCS device for this young patient population. This review provides an updated and integrated overview of the diagnostic flow and important clinical considerations when managing patients with FM.

Indexed as

Cardiogenic shockDiagnosisFulminant myocarditisManagementMechanical circulatory supportTreatment

Identifiers

PMID40302841
PMCPMC12036524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.